192 related articles for article (PubMed ID: 25465741)
1. In vivo model for mastocytosis: A comparative review.
Ranieri G; Marech I; Pantaleo M; Piccinno M; Roncetti M; Mutinati M; Rizzo A; Gadaleta CD; Introna M; Patruno R; Sciorsci RL
Crit Rev Oncol Hematol; 2015 Mar; 93(3):159-69. PubMed ID: 25465741
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
3. New insights into the pathogenesis, diagnosis, and management of mastocytosis.
Fuller SJ
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1143-68. PubMed ID: 23116574
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
5. Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options.
Afrin LB; Butterfield JH; Raithel M; Molderings GJ
Ann Med; 2016; 48(3):190-201. PubMed ID: 27012973
[TBL] [Abstract][Full Text] [Related]
6. Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.
Arock M; Akin C; Hermine O; Valent P
Eur J Haematol; 2015 Jun; 94(6):474-90. PubMed ID: 25753531
[TBL] [Abstract][Full Text] [Related]
7. Masitinib (AB1010), from canine tumor model to human clinical development: where we are?
Marech I; Patruno R; Zizzo N; Gadaleta C; Introna M; Zito AF; Gadaleta CD; Ranieri G
Crit Rev Oncol Hematol; 2014 Jul; 91(1):98-111. PubMed ID: 24405856
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract][Full Text] [Related]
10. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
11. Equine Cutaneous Mast Cell Tumours Exhibit Variable Differentiation, Proliferation Activity and KIT Expression.
Ressel L; Ward S; Kipar A
J Comp Pathol; 2015 Nov; 153(4):236-43. PubMed ID: 26292768
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
Akin C
J Mol Diagn; 2006 Sep; 8(4):412-9. PubMed ID: 16931579
[TBL] [Abstract][Full Text] [Related]
13. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
[TBL] [Abstract][Full Text] [Related]
15. Mastocytosis - an update.
Amon U; Hartmann K; Horny HP; Nowak A
J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis.
Metcalfe DD
Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
[TBL] [Abstract][Full Text] [Related]
17. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
18. [Guidelines for the diagnosis, treatment and management of mastocytosis].
De la Hoz B; González de Olano D; Alvarez I; Sánchez L; Núñez R; Sánchez I; Escribano L
An Sist Sanit Navar; 2008; 31(1):11-32. PubMed ID: 18496577
[TBL] [Abstract][Full Text] [Related]
19. Mastocytosis: recent advances in defining the disease.
Hartmann K; Henz BM
Br J Dermatol; 2001 Apr; 144(4):682-95. PubMed ID: 11298525
[TBL] [Abstract][Full Text] [Related]
20. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
